Publications by authors named "Timothy R Cote"

Claim this Profile
T
The need for worldwide policy and action plans for rare diseases.
John Forman, Domenica Taruscio, Virginia A Llera, Luis A Barrera, Timothy R Coté

Acta Paediatr· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacology as a cornerstone of orphan drug development.
Edward D Bashaw, Shiew-Mei Huang, Timothy R Coté, Anne R Pariser, Christine E Garnett

Nat Rev Drug Discov· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases.
Kui Xu, Timothy R Coté

Brief Bioinform· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory considerations for developing drugs for rare diseases: orphan designations and early phase clinical trials.
Anne R Pariser, Kui Xu, John Milto, Timothy R Coté

Discov Med· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating orphan drug development.
Timothy R Coté, Kui Xu, Anne R Pariser

Nat Rev Drug Discov· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Orphan Drug Act and the development of stem cell-based products for rare diseases.
Scott N Freeman, Kathryn A Burke, Menfo A Imoisili, Timothy R Coté

Cell Stem Cell· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years.
M Miles Braun, Sheiren Farag-El-Massah, Kui Xu, Timothy R Coté

Nat Rev Drug Discov· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapies for inborn errors of metabolism: what has the orphan drug act delivered?
Sonali S Talele, Kui Xu, Anne R Pariser, M Miles Braun, Sheiren Farag-El-Massah

Pediatrics· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duchenne muscular dystrophy: Drug development and regulatory considerations.
D Elizabeth McNeil, Carole Davis, Devanand Jillapalli, Shari Targum, Anthony Durmowicz

Muscle Nerve· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin.
Timothy R Coté, Leslie H Sobin

Melanoma Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous cultured chondrocytes: adverse events reported to the United States Food and Drug Administration.
Jennifer J Wood, Mark A Malek, Frank J Frassica, Jacquelyn A Polder, Aparna K Mohan

J Bone Joint Surg Am· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.
Timothy R Coté, Aparna K Mohan, Jacquelyn A Polder, Marc K Walton, M Miles Braun

J Am Acad Dermatol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissues from population-based cancer registries: a novel approach to increasing research potential.
Marc T Goodman, Brenda Y Hernandez, Stephen Hewitt, Charles F Lynch, Timothy R Coté

Hum Pathol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray.
Brenda Y Hernandez, Henry F Frierson, Christopher A Moskaluk, Yu Jim Li, Limin Clegg, Timothy R Cote

Hum Pathol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor.
Aparna K Mohan, Timothy R Coté, Joel A Block, Augustine M Manadan, Jeffrey N Siegel

Clin Infect Dis· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deaths among children less than two years of age receiving palivizumab: an analysis of comorbidities.
Aparna K Mohan, M Miles Braun, Susan Ellenberg, Judith Hedje, Timothy R Coté

Pediatr Infect Dis J· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
Mark E Sherman, Pamela J Mink, Rochelle Curtis, Timothy R Cote, Sandra Brooks

Cancer· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infectious complications of biologic treatments of rheumatoid arthritis.
Aparna K Mohan, Timothy R Coté, Jeffrey N Siegel, M Miles Braun

Curr Opin Rheumatol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathology and classification of ovarian tumors.
Vivien W Chen, Bernardo Ruiz, Jeffrey L Killeen, Timothy R Coté, Xiao Cheng Wu

Cancer· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case reports of heart failure after therapy with a tumor necrosis factor antagonist.
Hyon J Kwon, Timothy R Coté, Michael S Cuffe, Judith M Kramer, M Miles Braun

Ann Intern Med· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine tumors of the uterine cervix: incidence, demographics, and survival with comparison to squamous cell carcinoma.
Margaret E McCusker, Timothy R Coté, Limin X Clegg, Fattaneh J Tavassoli

Gynecol Oncol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SEER update of incidence and trends in pediatric malignancies: acute lymphoblastic leukemia.
Dawn Elizabeth McNeil, Timothy R Coté, Limin Clegg, Alvin Mauer

Med Pediatr Oncol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results.
Dawn Elizabeth McNeil, Timothy R Coté, Limin Clegg, Lucy Balian Rorke

Med Pediatr Oncol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-induced systemic lupus erythematosus and TNF-alpha blockers.
Aparna K Mohan, Evelyne T Edwards, Timothy R Coté, Jeffrey N Siegel, M Miles Braun

Lancet· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998.
Margaret E McCusker, Timothy R Coté, Limin X Clegg, Leslie H Sobin

Cancer· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis